Trend Results : "Prostate Cancer"


Related Searches

Blog Post Results (1-20 of 3739)

FILTER RESULTS

Medical News Today: How nerves fuel prostate cancer growth

Researchers from the Albert Einstein College of Medicine have pinpointed how certain nerves drive the growth of prostate cancer using a metabolic 'switch.'

Study shows how nerves drive prostate cancer

(Albert Einstein College of Medicine) In a study in today's issue of Science, researchers at Albert Einstein College of Medicine, part of Montefiore Medicine, report that certain nerves sustain prostate cancer growth by triggering a switch that causes tumor vessels to proliferate. Show More Summary

Fundamental research enhances understanding of major cancer gene

Scientists have provided new insights into the role of PTEN, a major cancer gene, in controlling cell growth and behavior. PTEN is the second most commonly altered gene in human cancers, particularly prostate cancers, and this work could help to develop and target new treatments.

Study Shows How Nerves Drive Prostate Cancer

In a study in today's issue of Science, researchers at Albert Einstein College of Medicine, part of Montefiore Medicine, report that certain nerves sustain prostate cancer growth by triggering a switch that causes tumor vessels to proliferate. Show More Summary

Medical News Today: Hormone therapy for prostate cancer increases cardiac risk

Androgen-deprivation therapy is widely used to treat prostate cancer. In a recent study, the potential risks to heart health are examined.

Researchers reveal biomarker for guiding prostate cancer treatment

Back-to-back discoveries demonstrate for the first time how a testosterone-related genetic abnormality can help predict individual patient responses to specific prostate cancer therapies. The studies suggest that men who inherit this variant would benefit from a personalized treatment plan that targets specific hormonal pathways.

PSA tests aren't great for diagnosing prostate cancer. Here are some better options in the works

The PSA test is an imperfect way to screen men for prostate cancer. But now, doctors have new tools to help them detect and manage the often-perplexing disease.

Medical News Today: Everything you need to know about prostate nodules

A prostate nodule is a firm, knuckle-like area on the prostate. There are several causes of prostate nodules, including prostatitis and prostate cancer.

Cleveland Clinic researchers reveal biomarker for guiding prostate cancer treatment

(Cleveland Clinic) Back-to-back discoveries from Cleveland Clinic demonstrate for the first time how a testosterone-related genetic abnormality can help predict individual patient responses to specific prostate cancer therapies. The studies, published in the Oct. Show More Summary

Medical News Today: All you need to know about the PCA3 test

The PCA3 test can help doctors diagnose prostate cancer. Learn about the test, what to expect, and other testing options with this article.

Life after cancer: “The real battle happened after treatment”

Bin McLaurin was lucky. Doctors detected his prostate cancer early, and he successfully completed the surgery, radiation and hormone therapy he needed to keep the disease at bay. But two years out from his 2014 diagnosis, McLaurin didn't feel so great. He had gained 60 pounds during treatment,...

Prostate cancer patients unclear on differences among treatments

(Reuters Health) - Many patients with localized prostate cancer don’t understand the differences between their treatment options, a new study suggests.

Medical News Today: Despite concerns, vasectomy and prostate cancer not linked

A debate that has raged for more than 30 years may finally be over: prostate cancer risk does not seem to be increased following a vasectomy.

Cherished Daily News editor Mark Mooney dies of cancer at 66

last weekNews : NY Daily News

Mark Mooney, a newsroom favorite at the Daily News, died Friday after a lengthy bout with prostate cancer.

New Biomarker Predicts Metastatic Prostate Cancers

Many prostate cancers, which generally are diagnosed in older men, are "indolent," slow-growing tumors that aren't destined to be fatal. But some tumors are prone to becoming aggressive and spreading beyond the prostate, making them difficult to treat and life-threatening. Show More Summary

Androgen receptor targeted imaging of prostate cancer as future modality for diagnosis

(Bentham Science Publishers) Future direction in prostate cancer imaging involves the development of androgen receptor based imaging using nonsteroidal antiandrogen agent for early diagnosis of prostate cancer.

Androgen receptor targeted imaging of prostate cancer as future modality for diagnosis

Prostate cancer is the second most prevailing cancer among men worldwide. In the most cases, prostate cancer is slowly progressing, whereas, in some cases, it is a rapidly progressing disease with a significantly high mortality rate....Show More Summary

THE SCIENCE IS SETTLED: Men Who Ejaculate More at Reduced Risk for Prostate Cancer, Studies Suggest….

THE SCIENCE IS SETTLED: Men Who Ejaculate More at Reduced Risk for Prostate Cancer, Studies Suggest.

New targeted alpha therapy protocol for advanced prostate cancer

Therapy options are limited for men with advanced-stage, metastatic castration-resistant prostate cancer, but a new treatment protocol offers hope. Researchers report on their novel dosing regimen for actinium-225-labeled targeted alpha therapy of patients with prostate specific membrane antigen (PSMA)-positive tumors. Show More Summary

New targeted alpha therapy protocol for advanced prostate cancer

(Society of Nuclear Medicine and Molecular Imaging) Therapy options are limited for men with advanced-stage, metastatic castration-resistant prostate cancer, but a new treatment protocol offers hope. In the featured article of The Journal...Show More Summary

Copyright © 2015 Regator, LLC